The final leg of the ABC correction appears to have completed with a clear five-wave decline into liquidity. Price has now breached Wave 4, confirming a Break of Structure (BOS) and signaling a shift in the state of delivery.
With BOS established, we now focus on the impulse leg upward, which not only breaks structure but also aligns with a 2 standard deviation expansion—our projected target zone.
Trade Parameters:
Entry: 2.41 USDT
Stop Loss: 2.14 USDT (-11.34%)
Target: 4.00 USDT (+68.52%)
Risk-to-Reward Ratio: 5.79R
Market Outlook:
The Breaker Block retest would have been the ideal zone to re enter for continuation.
A strong reaction from this level confirms strength for further upside.
Failure to hold the breaker structure will invalidate the bullish scenario.
This is a high R:R setup—execute with precision, manage risk, and let price do the work.
Let’s ride the wave to 4.00 USDT! 🚀
LordMEDZ
With BOS established, we now focus on the impulse leg upward, which not only breaks structure but also aligns with a 2 standard deviation expansion—our projected target zone.
Trade Parameters:
Entry: 2.41 USDT
Stop Loss: 2.14 USDT (-11.34%)
Target: 4.00 USDT (+68.52%)
Risk-to-Reward Ratio: 5.79R
Market Outlook:
The Breaker Block retest would have been the ideal zone to re enter for continuation.
A strong reaction from this level confirms strength for further upside.
Failure to hold the breaker structure will invalidate the bullish scenario.
This is a high R:R setup—execute with precision, manage risk, and let price do the work.
Let’s ride the wave to 4.00 USDT! 🚀
LordMEDZ
Trade active
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Lord MEDZ
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.